Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Industry Summary Page

Industry: pharmaceuticals
Penalty Total since 2000: $114,359,306,358
Number of Records: 1,225
Note: The totals include only those entries matched to a parent company. The industry designation is the primary one for the parent's operations overall. The totals are adjusted to account for the fact that each parent's entries may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. They are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the individual records list below.
Top 10 Current Parent CompaniesTotal Penalty $Number of Records
Johnson & Johnson$24,347,649,47086
Pfizer$10,945,838,54996
Merck$10,654,360,58186
Teva Pharmaceutical Industries$10,046,817,45593
GlaxoSmithKline$9,572,803,40650
Purdue Pharma$9,278,372,78711
AbbVie$7,460,350,02475
Takeda Pharmaceutical$3,987,516,44732
Novartis$3,078,079,57044
Endo International$2,847,090,66729

Individual Penalty Records:

Click on the company or penalty amount for more information on each case. Click on the parent name to reach the summary page for that parent company.

Download results as CSV or XML or Save your search (Click here for information on download subscriptions)
CompanyCurrent ParentPrimary Offense TypeYearAgencyPenalty Amount sort icon .
Johnson & JohnsonJohnson & Johnsonproduct safety violation2023private lawsuit-federal$8,900,000,000
Purdue Pharma LPPurdue Pharmafraud2020DOJ_CIVIL$8,344,000,000
Johnson & JohnsonJohnson & Johnsonoff-label or unapproved promotion of medical products2021MULTI-AG$5,000,000,000
Merck & Co.Merckdrug or medical equipment safety violation2007private lawsuit-federal$4,850,000,000
Teva PharmaceuticalsTeva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2022MULTI-AG$4,250,000,000
American Home ProductsPfizerdrug or medical equipment safety violation2002private lawsuit-federal$3,750,000,000
GlaxoSmithKline Holdings (Americas)GlaxoSmithKlinetax violations2006IRS$3,400,000,000
GlaxoSmithKline LLCGlaxoSmithKlineoff-label or unapproved promotion of medical products2012FDA$3,000,000,000
Johnson & JohnsonJohnson & Johnsonproduct safety violation2021private lawsuit-federal$2,500,000,000
DePuy Orthopaedics, Inc.Johnson & Johnsondrug or medical equipment safety violation2013private lawsuit-federal$2,475,000,000
Takeda Pharmaceutical Co. Ltd.Takeda Pharmaceuticaldrug or medical equipment safety violation2015private lawsuit-federal$2,400,000,000
AllerganAbbVieoff-label or unapproved promotion of medical products2022MULTI-AG$2,370,000,000
Pfizer Inc.Pfizeroff-label or unapproved promotion of medical products2009FDA$2,300,000,000
Merck & Co., Inc.Mercktax violations2007IRS$2,300,000,000
Johnson & JohnsonJohnson & Johnsonoff-label or unapproved promotion of medical products2013FDA$2,200,000,000
MallinckrodtMallinckrodtControlled Substances Act violation2020MULTI-AG$1,600,000,000
Abbott Laboratories Inc.AbbVieoff-label or unapproved promotion of medical products2012FDA$1,500,000,000
Eli Lilly and CompanyEli Lillyoff-label or unapproved promotion of medical products2009FDA$1,415,000,000
Cephalon, Inc.Teva Pharmaceutical Industriesprice-fixing or anti-competitive practices2015FTC$1,200,000,000
Merck, Sharp & DohmeMerckoff-label or unapproved promotion of medical products2011FDA$950,000,000
Biogen Inc.BiogenFalse Claims Act and related2022DOJ_CIVIL$900,000,000
TAP Pharmaceutical Products Inc.Takeda PharmaceuticalFalse Claims Act and related2001DOJ_CIVIL$875,000,000
Endo International PLCEndo Internationaldrug or medical equipment safety violation2014private lawsuit-federal$830,000,000
Pfizer Inc.PfizerFalse Claims Act and related2016DOJ_CIVIL$784,600,000
Endo International PLCEndo Internationaldrug or medical equipment safety violation2017private lawsuit-federal$775,000,000
GlaxoSmithKlineGlaxoSmithKlinedrug or medical equipment safety violation2010private lawsuit-federal$770,000,000
Amgen Inc.Amgenoff-label or unapproved promotion of medical products2012FDA$762,000,000
SB Pharmco Puerto Rico Inc.GlaxoSmithKlinedrug or medical equipment safety violation2010FDA$750,000,000
PfizerPfizerdrug or medical equipment safety violation2004private lawsuit-federal$750,000,000
Forest Laboratories LLCAbbVieprice-fixing or anti-competitive practices2020private lawsuit-federal$750,000,000
PfizerPfizerdrug or medical equipment safety violation2008private lawsuit-federal$745,000,000
Serono, S.A.Merck KGaA (EMD)off-label or unapproved promotion of medical products2005FDA$704,000,000
Eli Lilly and CompanyEli Lillydrug or medical equipment safety violation2005private lawsuit-federal$690,000,000
Merck & CompanyMerckFalse Claims Act and related2008DOJ_CIVIL$650,000,000
Boehringer Ingelheim InternationalBoehringer Ingelheimdrug or medical equipment safety violation2014private lawsuit-federal$650,000,000
Novartis Pharmaceuticals CorporationNovartisFalse Claims Act and related2020DOJ_CIVIL(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $642,000,000
Amgen Inc.Amgenoff-label or unapproved promotion of medical products2012MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $612,000,000
Allergan Inc.AbbVieoff-label or unapproved promotion of medical products2010FDA$600,000,000
Abbott Laboratories and CG NutritionalsAbbott LaboratoriesFalse Claims Act and related2003DOJ_CIVIL$600,000,000
Purdue Frederick Company Inc.Purdue PharmaFalse Claims Act and related2007USAO$600,000,000
Indivior SolutionsIndivior PLCFalse Claims Act and related2020DOJ_CIVIL$589,000,000
Johnson & JohnsonJohnson & Johnsonoff-label or unapproved promotion of medical products2013MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $541,000,000
AstraZeneca LPAstraZenecaoff-label or unapproved promotion of medical products2010FDA$520,000,000
Bristol-Myers Squibb CompanyBristol-Myers Squibboff-label or unapproved promotion of medical products2007DOJ_CIVIL$515,000,000
Teva Pharmaceuticals USA Inc.Teva Pharmaceutical Industriesprice-fixing or anti-competitive practices2015private lawsuit-federal$512,000,000
Ranbaxy USA Inc.Sun Pharmaceuticalsdrug or medical equipment safety violation2013FDA$500,000,000
Schering-Plough CorporationMerckdrug or medical equipment safety violation2002DOJ_CIVIL$500,000,000
Eli Lilly and CompanyEli Lillydrug or medical equipment safety violation2007private lawsuit-federal$500,000,000
Wyeth Pharmaceuticals Inc.Pfizeroff-label or unapproved promotion of medical products2013FDA$490,900,000
Ranbaxy, Inc.Sun Pharmaceuticalsprice-fixing or anti-competitive practices2022private lawsuit-federal$485,000,000
GlaxoSmithKlineGlaxoSmithKlineoff-label or unapproved promotion of medical products2012MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $477,792,391
Mylan Inc.ViatrisFalse Claims Act and related2017DOJ_CIVIL$465,000,000
Mylan Inc.ViatrisFalse Claims Act and related2017MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $465,000,000
Endo International plcEndo Internationaloff-label or unapproved promotion of medical products2022MULTI-AG$450,000,000
Schering-Plough CorporationMerckoff-label or unapproved promotion of medical products2006USAO$435,000,000
Warner-LambertPfizeroff-label or unapproved promotion of medical products2004FDA$430,000,000
Cephalon IncTeva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2008FDA$425,000,000
Novartis Pharmaceuticals CorporationNovartisoff-label or unapproved promotion of medical products2010FDA$422,500,000
Janssen Pharmaceuticals, Inc.Johnson & Johnsonoff-label or unapproved promotion of medical products2013USAO$410,000,000
Novartis PharmaceuticalsNovartiskickbacks and bribery2015USAO$390,000,000
Janssen PharmaceuticalsJohnson & Johnsondrug or medical equipment safety violation2019private lawsuit-federal$387,500,000
Wyeth Pharmaceuticals, Inc.PfizerFalse Claims Act and related2016MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $371,351,180
Eli Lilly and CompanyEli Lillyoff-label or unapproved promotion of medical products2009MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $361,828,456
Actelion Pharmaceuticals US, Inc.Johnson & JohnsonFalse Claims Act and related2018DOJ_CIVIL$360,000,000
AstraZeneca Pharmaceuticals LPAstraZenecaFalse Claims Act and related2003DOJ_CIVIL$354,900,000
Shire Pharmaceuticals LLCTakeda PharmaceuticalFalse Claims Act and related2017DOJ_CIVIL$350,000,000
Schering-Plough CorporationMerckkickbacks and bribery2004DOJ_CIVIL$345,000,000
Pfizer Inc.Pfizerprice-fixing or anti-competitive practices2021private lawsuit-federal$345,000,000
Abbott LaboratoriesAbbVieoff-label or unapproved promotion of medical products2012MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $339,148,643
Pfizer, Inc.Pfizerkickbacks and bribery2009MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $331,485,170
Teva Pharmaceuticals, Ltd.Teva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2022NY-AG$313,343,793
Johnson and JohnsonJohnson & Johnsonproduct safety violation2023CA-AG$302,000,000
Bristol-Myers SquibbBristol-Myers Squibbfraud2005USAO$300,000,000
Indivior plcIndivior PLCoff-label or unapproved promotion of medical products2021MULTI-AG$300,000,000
Daiichi Sankyo Inc.Daiichi Sankyoproduct safety violation2017private lawsuit-federal$300,000,000
Bausch Health Companies Inc.Bausch Healthprice-fixing or anti-competitive practices2022private lawsuit-federal$300,000,000
Schering-Plough CorporationMerckkickbacks and bribery2004MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $292,969,482
MerckMerckFalse Claims Act and related2008MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $290,000,000
PfizerPfizerdrug or medical equipment safety violation2013private lawsuit-federal$288,000,000
Teva Pharmaceutical Industries LtdTeva Pharmaceutical IndustriesForeign Corrupt Practices Act2016DOJ_CRIMINAL$283,177,348
Dey Inc.ViatrisFalse Claims Act and related2010DOJ_CIVIL$280,000,000
Roxane Laboratories Inc.Hikma PharmaceuticalsFalse Claims Act and related2010DOJ_CIVIL$280,000,000
Celgene Corp.Bristol-Myers SquibbFalse Claims Act and related2017USAO$280,000,000
Teva Pharmaceutical IndustriesTeva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2022FL-AG$278,826,499
Teva Pharmaceuticals USA, Inc.Teva Pharmaceutical Industriesprice-fixing or anti-competitive practices2023DOJ_ANTITRUST$275,000,000
Purdue PharmaPurdue PharmaControlled Substances Act violation2019OK-AG$270,000,000
Teva Pharmaceuticals Industries Ltd.Teva Pharmaceutical Industriesproduct safety violation2012private lawsuit-federal$270,000,000
RanbaxySun Pharmaceuticalsdrug or medical equipment safety violation2013MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $266,729,715
Mylan N.V.Viatrisprice-fixing or anti-competitive practices2022private lawsuit-federal$264,000,000
Serono Inc.Merck KGaA (EMD)off-label or unapproved promotion of medical products2005MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $262,000,000
Mallinckrodt ARD LLCMallinckrodtFalse Claims Act and related2022DOJ_CIVIL$260,000,000
Wyeth Pharmaceuticals, Inc.Pfizeroff-label or unapproved promotion of medical products2013MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $257,400,000
Abbott LaboratoriesAbbVieprice-fixing or anti-competitive practices2009private lawsuit-federal$250,000,000
Teva Pharmaceutical Industries LimitedTeva Pharmaceutical IndustriesForeign Corrupt Practices Act2016SEC$236,000,000
Novartis Hellas S.A.C.I. et al.NovartisForeign Corrupt Practices Act2020DOJ_CRIMINAL$233,000,000
Teva Pharmaceutical Industries Ltd.Teva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2022TX-AG$225,000,000
Barr Laboratories Inc.Teva Pharmaceutical Industriesprice-fixing or anti-competitive practices2017private lawsuit-state$225,000,000
Bristol-Myers Squibb CompanyBristol-Myers Squibbprice-fixing or anti-competitive practices2003private lawsuit-federal$220,000,000
AstraZeneca Pharmaceuticals LPAstraZenecaoff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $218,092,993
Taro Pharmaceuticals USA, Inc.Sun PharmaceuticalsFalse Claims Act and related2021DOJ_CIVIL$213,200,000
United Therapeutics CorporationUnited TherapeuticsFalse Claims Act and related2017DOJ_CIVIL$210,000,000
(*): Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting.